glp-1 prior authorization Market Access: PBM Auth & First-Fill Metrics Tackling GLP-1 Medication Growth with

3.5 Rapid Weight Loss and Lean Mass Reduction Weight loss during GLP-1 therapy includes: Adipose tissue Lean body mass Data from obesity trials indicate that without resistance training and adequate protein intake, a meaningful proportion of weight lost may be lean mass. Reduced protein intake may indirectly influence: Iron intake Zinc intake B12 intake This creates a secondary nutrient risk pathway unrelated to absorption but related to dietary composition

Youll want to discuss your options with your provider and also talk to the doctor who is treating your condition before you schedule an injectable treatment

Women of childbearing potential should note that Mounjaro is not recommended during pregnancy or breastfeeding, and additional contraceptive methods are advised for 4 weeks after starting treatment and after each dose increase

doi: 10.3390/antiox11112105